The Phenobarbitone (Gardinal) test is a therapeutic drug monitoring blood test used to measure the level of phenobarbitone; a barbiturate prescribed for epilepsy and seizure disorders. Since phenobarbitone has a narrow therapeutic range, monitoring is essential to ensure effective seizure control while avoiding toxicity. This test is performed to guide dosage adjustments, assess treatment compliance, and prevent side effects such as drowsiness, confusion, or respiratory depression, ensuring safe and effective long-term management of patients on phenobarbitone therapy.
It helps prevent underdosing, which may cause seizures, and overdosing, which can lead to toxicity and serious side effects.
Patients taking phenobarbitone for epilepsy or seizure disorders are recommended for regular monitoring.
Low levels may indicate inadequate seizure control, requiring dose adjustment.
High levels suggest toxicity, which can cause drowsiness, confusion, or respiratory depression.
Yes, other drugs may interact with phenobarbitone, altering its blood levels.
Without monitoring, patients risk uncontrolled seizures or dangerous drug toxicity.
Yes, regular monitoring and dose adjustments help prevent toxicity.
Phenobarbitone is mainly prescribed for epilepsy, seizure disorders, and sometimes anxiety or sleep issues.
...
Didn't recieved OTP Yet? Resend OTP